MUMBAI May 25 Cipla Ltd, India's
fifth-largest drugmaker by sales, reported a smaller quarterly
loss for January-March, but missed expectations of a profit for
Net loss for the firm's fourth quarter narrowed to 617.9
million rupees ($9.56 million) from a loss of 928.3 million
rupees a year earlier.
Analysts on average had expected the firm would report a
profit of 3.45 billion rupees.
The quarter includes a one-off non-cash impairment charge of
21.42 billion rupees related to litigation expenses, and the
company also took a provision of 560 million rupees related to
its unit Cipla Biotech in the quarter, it said in a statement.
($1 = 64.6125 Indian rupees)
(Reporting by Zeba Siddiqui in Mumbai; Editing by Edmund Blair)